0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meropenem Powder Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-8D10881
Home | Market Reports | Health| Pharmacy
Global Meropenem Powder Market Research Report 2022
BUY CHAPTERS

Global Meropenem Powder Market Research Report 2025

Code: QYRE-Auto-8D10881
Report
February 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meropenem Powder Market

The global market for Meropenem Powder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Meropenem Powder is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Meropenem Powder is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Meropenem Powder include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals, Macleods Pharmaceuticals, Shenzhen Haibin Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meropenem Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meropenem Powder.
The Meropenem Powder market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meropenem Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meropenem Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meropenem Powder Market Report

Report Metric Details
Report Name Meropenem Powder Market
Segment by Type
  • Purity Greater than or Equal to 98%
  • Purity Greater than or Equal to 99%
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals, Macleods Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Chongqing Tiandi Pharmaceutical, PKU HealthCare, United Laboratories, CSPC Group, Zhejiang Hisun Pharmaceutical, Luoxin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meropenem Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meropenem Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meropenem Powder Market report?

Ans: The main players in the Meropenem Powder Market are Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals, Macleods Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Chongqing Tiandi Pharmaceutical, PKU HealthCare, United Laboratories, CSPC Group, Zhejiang Hisun Pharmaceutical, Luoxin Pharmaceutical

What are the Application segmentation covered in the Meropenem Powder Market report?

Ans: The Applications covered in the Meropenem Powder Market report are Skin Infection, Bacterial Meningitis, Pneumonia, Others

What are the Type segmentation covered in the Meropenem Powder Market report?

Ans: The Types covered in the Meropenem Powder Market report are Purity Greater than or Equal to 98%, Purity Greater than or Equal to 99%

Recommended Reports

Pharmaceutical Powders

Specialty Metal Powders

Medical Application Powders

1 Meropenem Powder Market Overview
1.1 Product Definition
1.2 Meropenem Powder by Type
1.2.1 Global Meropenem Powder Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity Greater than or Equal to 98%
1.2.3 Purity Greater than or Equal to 99%
1.3 Meropenem Powder by Application
1.3.1 Global Meropenem Powder Market Value by Application (2024 VS 2031)
1.3.2 Skin Infection
1.3.3 Bacterial Meningitis
1.3.4 Pneumonia
1.3.5 Others
1.4 Global Meropenem Powder Market Size Estimates and Forecasts
1.4.1 Global Meropenem Powder Revenue 2020-2031
1.4.2 Global Meropenem Powder Sales 2020-2031
1.4.3 Global Meropenem Powder Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meropenem Powder Market Competition by Manufacturers
2.1 Global Meropenem Powder Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meropenem Powder Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meropenem Powder Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meropenem Powder, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meropenem Powder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meropenem Powder, Product Type & Application
2.7 Global Key Manufacturers of Meropenem Powder, Date of Enter into This Industry
2.8 Global Meropenem Powder Market Competitive Situation and Trends
2.8.1 Global Meropenem Powder Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meropenem Powder Players Market Share by Revenue
2.8.3 Global Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meropenem Powder Market Scenario by Region
3.1 Global Meropenem Powder Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meropenem Powder Sales by Region: 2020-2031
3.2.1 Global Meropenem Powder Sales by Region: 2020-2025
3.2.2 Global Meropenem Powder Sales by Region: 2026-2031
3.3 Global Meropenem Powder Revenue by Region: 2020-2031
3.3.1 Global Meropenem Powder Revenue by Region: 2020-2025
3.3.2 Global Meropenem Powder Revenue by Region: 2026-2031
3.4 North America Meropenem Powder Market Facts & Figures by Country
3.4.1 North America Meropenem Powder Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meropenem Powder Sales by Country (2020-2031)
3.4.3 North America Meropenem Powder Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meropenem Powder Market Facts & Figures by Country
3.5.1 Europe Meropenem Powder Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meropenem Powder Sales by Country (2020-2031)
3.5.3 Europe Meropenem Powder Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meropenem Powder Market Facts & Figures by Region
3.6.1 Asia Pacific Meropenem Powder Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meropenem Powder Sales by Region (2020-2031)
3.6.3 Asia Pacific Meropenem Powder Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meropenem Powder Market Facts & Figures by Country
3.7.1 Latin America Meropenem Powder Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meropenem Powder Sales by Country (2020-2031)
3.7.3 Latin America Meropenem Powder Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meropenem Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Meropenem Powder Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meropenem Powder Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meropenem Powder Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Meropenem Powder Sales by Type (2020-2031)
4.1.1 Global Meropenem Powder Sales by Type (2020-2025)
4.1.2 Global Meropenem Powder Sales by Type (2026-2031)
4.1.3 Global Meropenem Powder Sales Market Share by Type (2020-2031)
4.2 Global Meropenem Powder Revenue by Type (2020-2031)
4.2.1 Global Meropenem Powder Revenue by Type (2020-2025)
4.2.2 Global Meropenem Powder Revenue by Type (2026-2031)
4.2.3 Global Meropenem Powder Revenue Market Share by Type (2020-2031)
4.3 Global Meropenem Powder Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meropenem Powder Sales by Application (2020-2031)
5.1.1 Global Meropenem Powder Sales by Application (2020-2025)
5.1.2 Global Meropenem Powder Sales by Application (2026-2031)
5.1.3 Global Meropenem Powder Sales Market Share by Application (2020-2031)
5.2 Global Meropenem Powder Revenue by Application (2020-2031)
5.2.1 Global Meropenem Powder Revenue by Application (2020-2025)
5.2.2 Global Meropenem Powder Revenue by Application (2026-2031)
5.2.3 Global Meropenem Powder Revenue Market Share by Application (2020-2031)
5.3 Global Meropenem Powder Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Meropenem Powder Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Company Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AuroMedics Meropenem Powder Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sandoz Meropenem Powder Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Company Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amneal Pharmaceuticals Meropenem Powder Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Sumitomo Dainippon Pharma
6.5.1 Sumitomo Dainippon Pharma Company Information
6.5.2 Sumitomo Dainippon Pharma Description and Business Overview
6.5.3 Sumitomo Dainippon Pharma Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sumitomo Dainippon Pharma Meropenem Powder Product Portfolio
6.5.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.6 Ranbaxy Laboratories
6.6.1 Ranbaxy Laboratories Company Information
6.6.2 Ranbaxy Laboratories Description and Business Overview
6.6.3 Ranbaxy Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ranbaxy Laboratories Meropenem Powder Product Portfolio
6.6.5 Ranbaxy Laboratories Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Meropenem Powder Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Company Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sagent Pharmaceuticals Meropenem Powder Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 Macleods Pharmaceuticals
6.9.1 Macleods Pharmaceuticals Company Information
6.9.2 Macleods Pharmaceuticals Description and Business Overview
6.9.3 Macleods Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Macleods Pharmaceuticals Meropenem Powder Product Portfolio
6.9.5 Macleods Pharmaceuticals Recent Developments/Updates
6.10 Shenzhen Haibin Pharmaceutical
6.10.1 Shenzhen Haibin Pharmaceutical Company Information
6.10.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.10.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Product Portfolio
6.10.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.11 Chongqing Tiandi Pharmaceutical
6.11.1 Chongqing Tiandi Pharmaceutical Company Information
6.11.2 Chongqing Tiandi Pharmaceutical Description and Business Overview
6.11.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Product Portfolio
6.11.5 Chongqing Tiandi Pharmaceutical Recent Developments/Updates
6.12 PKU HealthCare
6.12.1 PKU HealthCare Company Information
6.12.2 PKU HealthCare Description and Business Overview
6.12.3 PKU HealthCare Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.12.4 PKU HealthCare Meropenem Powder Product Portfolio
6.12.5 PKU HealthCare Recent Developments/Updates
6.13 United Laboratories
6.13.1 United Laboratories Company Information
6.13.2 United Laboratories Description and Business Overview
6.13.3 United Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.13.4 United Laboratories Meropenem Powder Product Portfolio
6.13.5 United Laboratories Recent Developments/Updates
6.14 CSPC Group
6.14.1 CSPC Group Company Information
6.14.2 CSPC Group Description and Business Overview
6.14.3 CSPC Group Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CSPC Group Meropenem Powder Product Portfolio
6.14.5 CSPC Group Recent Developments/Updates
6.15 Zhejiang Hisun Pharmaceutical
6.15.1 Zhejiang Hisun Pharmaceutical Company Information
6.15.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zhejiang Hisun Pharmaceutical Meropenem Powder Product Portfolio
6.15.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.16 Luoxin Pharmaceutical
6.16.1 Luoxin Pharmaceutical Company Information
6.16.2 Luoxin Pharmaceutical Description and Business Overview
6.16.3 Luoxin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Luoxin Pharmaceutical Meropenem Powder Product Portfolio
6.16.5 Luoxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meropenem Powder Industry Chain Analysis
7.2 Meropenem Powder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meropenem Powder Production Mode & Process Analysis
7.4 Meropenem Powder Sales and Marketing
7.4.1 Meropenem Powder Sales Channels
7.4.2 Meropenem Powder Distributors
7.5 Meropenem Powder Customer Analysis
8 Meropenem Powder Market Dynamics
8.1 Meropenem Powder Industry Trends
8.2 Meropenem Powder Market Drivers
8.3 Meropenem Powder Market Challenges
8.4 Meropenem Powder Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meropenem Powder Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meropenem Powder Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meropenem Powder Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meropenem Powder Sales (Ton) of Key Manufacturers (2020-2025)
 Table 5. Global Meropenem Powder Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meropenem Powder Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meropenem Powder Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meropenem Powder Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meropenem Powder, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meropenem Powder, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meropenem Powder, Product Type & Application
 Table 12. Global Key Manufacturers of Meropenem Powder, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meropenem Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Powder as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meropenem Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meropenem Powder Sales by Region (2020-2025) & (Ton)
 Table 18. Global Meropenem Powder Sales Market Share by Region (2020-2025)
 Table 19. Global Meropenem Powder Sales by Region (2026-2031) & (Ton)
 Table 20. Global Meropenem Powder Sales Market Share by Region (2026-2031)
 Table 21. Global Meropenem Powder Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meropenem Powder Revenue Market Share by Region (2020-2025)
 Table 23. Global Meropenem Powder Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meropenem Powder Revenue Market Share by Region (2026-2031)
 Table 25. North America Meropenem Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meropenem Powder Sales by Country (2020-2025) & (Ton)
 Table 27. North America Meropenem Powder Sales by Country (2026-2031) & (Ton)
 Table 28. North America Meropenem Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meropenem Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meropenem Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meropenem Powder Sales by Country (2020-2025) & (Ton)
 Table 32. Europe Meropenem Powder Sales by Country (2026-2031) & (Ton)
 Table 33. Europe Meropenem Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meropenem Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meropenem Powder Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meropenem Powder Sales by Region (2020-2025) & (Ton)
 Table 37. Asia Pacific Meropenem Powder Sales by Region (2026-2031) & (Ton)
 Table 38. Asia Pacific Meropenem Powder Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meropenem Powder Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meropenem Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meropenem Powder Sales by Country (2020-2025) & (Ton)
 Table 42. Latin America Meropenem Powder Sales by Country (2026-2031) & (Ton)
 Table 43. Latin America Meropenem Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meropenem Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meropenem Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meropenem Powder Sales by Country (2020-2025) & (Ton)
 Table 47. Middle East and Africa Meropenem Powder Sales by Country (2026-2031) & (Ton)
 Table 48. Middle East and Africa Meropenem Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meropenem Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meropenem Powder Sales (Ton) by Type (2020-2025)
 Table 51. Global Meropenem Powder Sales (Ton) by Type (2026-2031)
 Table 52. Global Meropenem Powder Sales Market Share by Type (2020-2025)
 Table 53. Global Meropenem Powder Sales Market Share by Type (2026-2031)
 Table 54. Global Meropenem Powder Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meropenem Powder Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meropenem Powder Revenue Market Share by Type (2020-2025)
 Table 57. Global Meropenem Powder Revenue Market Share by Type (2026-2031)
 Table 58. Global Meropenem Powder Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Meropenem Powder Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Meropenem Powder Sales (Ton) by Application (2020-2025)
 Table 61. Global Meropenem Powder Sales (Ton) by Application (2026-2031)
 Table 62. Global Meropenem Powder Sales Market Share by Application (2020-2025)
 Table 63. Global Meropenem Powder Sales Market Share by Application (2026-2031)
 Table 64. Global Meropenem Powder Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meropenem Powder Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meropenem Powder Revenue Market Share by Application (2020-2025)
 Table 67. Global Meropenem Powder Revenue Market Share by Application (2026-2031)
 Table 68. Global Meropenem Powder Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Meropenem Powder Price (US$/Kg) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Pfizer Meropenem Powder Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AuroMedics Company Information
 Table 76. AuroMedics Description and Business Overview
 Table 77. AuroMedics Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. AuroMedics Meropenem Powder Product
 Table 79. AuroMedics Recent Developments/Updates
 Table 80. Sandoz Company Information
 Table 81. Sandoz Description and Business Overview
 Table 82. Sandoz Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Sandoz Meropenem Powder Product
 Table 84. Sandoz Recent Developments/Updates
 Table 85. Amneal Pharmaceuticals Company Information
 Table 86. Amneal Pharmaceuticals Description and Business Overview
 Table 87. Amneal Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Amneal Pharmaceuticals Meropenem Powder Product
 Table 89. Amneal Pharmaceuticals Recent Developments/Updates
 Table 90. Sumitomo Dainippon Pharma Company Information
 Table 91. Sumitomo Dainippon Pharma Description and Business Overview
 Table 92. Sumitomo Dainippon Pharma Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Sumitomo Dainippon Pharma Meropenem Powder Product
 Table 94. Sumitomo Dainippon Pharma Recent Developments/Updates
 Table 95. Ranbaxy Laboratories Company Information
 Table 96. Ranbaxy Laboratories Description and Business Overview
 Table 97. Ranbaxy Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Ranbaxy Laboratories Meropenem Powder Product
 Table 99. Ranbaxy Laboratories Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Mylan Meropenem Powder Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Sagent Pharmaceuticals Company Information
 Table 106. Sagent Pharmaceuticals Description and Business Overview
 Table 107. Sagent Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Sagent Pharmaceuticals Meropenem Powder Product
 Table 109. Sagent Pharmaceuticals Recent Developments/Updates
 Table 110. Macleods Pharmaceuticals Company Information
 Table 111. Macleods Pharmaceuticals Description and Business Overview
 Table 112. Macleods Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Macleods Pharmaceuticals Meropenem Powder Product
 Table 114. Macleods Pharmaceuticals Recent Developments/Updates
 Table 115. Shenzhen Haibin Pharmaceutical Company Information
 Table 116. Shenzhen Haibin Pharmaceutical Description and Business Overview
 Table 117. Shenzhen Haibin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Shenzhen Haibin Pharmaceutical Meropenem Powder Product
 Table 119. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
 Table 120. Chongqing Tiandi Pharmaceutical Company Information
 Table 121. Chongqing Tiandi Pharmaceutical Description and Business Overview
 Table 122. Chongqing Tiandi Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Chongqing Tiandi Pharmaceutical Meropenem Powder Product
 Table 124. Chongqing Tiandi Pharmaceutical Recent Developments/Updates
 Table 125. PKU HealthCare Company Information
 Table 126. PKU HealthCare Description and Business Overview
 Table 127. PKU HealthCare Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. PKU HealthCare Meropenem Powder Product
 Table 129. PKU HealthCare Recent Developments/Updates
 Table 130. United Laboratories Company Information
 Table 131. United Laboratories Description and Business Overview
 Table 132. United Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 133. United Laboratories Meropenem Powder Product
 Table 134. United Laboratories Recent Developments/Updates
 Table 135. CSPC Group Company Information
 Table 136. CSPC Group Description and Business Overview
 Table 137. CSPC Group Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 138. CSPC Group Meropenem Powder Product
 Table 139. CSPC Group Recent Developments/Updates
 Table 140. Zhejiang Hisun Pharmaceutical Company Information
 Table 141. Zhejiang Hisun Pharmaceutical Description and Business Overview
 Table 142. Zhejiang Hisun Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 143. Zhejiang Hisun Pharmaceutical Meropenem Powder Product
 Table 144. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 145. Luoxin Pharmaceutical Company Information
 Table 146. Luoxin Pharmaceutical Description and Business Overview
 Table 147. Luoxin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 148. Luoxin Pharmaceutical Meropenem Powder Product
 Table 149. Luoxin Pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Meropenem Powder Distributors List
 Table 153. Meropenem Powder Customers List
 Table 154. Meropenem Powder Market Trends
 Table 155. Meropenem Powder Market Drivers
 Table 156. Meropenem Powder Market Challenges
 Table 157. Meropenem Powder Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meropenem Powder
 Figure 2. Global Meropenem Powder Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meropenem Powder Market Share by Type: 2024 & 2031
 Figure 4. Purity Greater than or Equal to 98% Product Picture
 Figure 5. Purity Greater than or Equal to 99% Product Picture
 Figure 6. Global Meropenem Powder Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Meropenem Powder Market Share by Application: 2024 & 2031
 Figure 8. Skin Infection
 Figure 9. Bacterial Meningitis
 Figure 10. Pneumonia
 Figure 11. Others
 Figure 12. Global Meropenem Powder Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Meropenem Powder Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Meropenem Powder Sales (2020-2031) & (Ton)
 Figure 15. Global Meropenem Powder Average Price (US$/Kg) & (2020-2031)
 Figure 16. Meropenem Powder Report Years Considered
 Figure 17. Meropenem Powder Sales Share by Manufacturers in 2024
 Figure 18. Global Meropenem Powder Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Meropenem Powder Players: Market Share by Revenue in Meropenem Powder in 2024
 Figure 20. Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Meropenem Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Meropenem Powder Sales Market Share by Country (2020-2031)
 Figure 23. North America Meropenem Powder Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Meropenem Powder Sales Market Share by Country (2020-2031)
 Figure 27. Europe Meropenem Powder Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Meropenem Powder Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Meropenem Powder Revenue Market Share by Region (2020-2031)
 Figure 35. China Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Meropenem Powder Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Meropenem Powder Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Meropenem Powder Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Meropenem Powder Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Meropenem Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Meropenem Powder by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Meropenem Powder by Type (2020-2031)
 Figure 57. Global Meropenem Powder Price (US$/Kg) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Meropenem Powder by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Meropenem Powder by Application (2020-2031)
 Figure 60. Global Meropenem Powder Price (US$/Kg) by Application (2020-2031)
 Figure 61. Meropenem Powder Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart